Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment

Neuromuscul Disord. 2012 Aug;22(8):767-70. doi: 10.1016/j.nmd.2012.04.004. Epub 2012 May 29.

Abstract

Capecitabine plus oxaliplatin combination (XELOX) is the first-line treatment in metastatic colorectal cancer. Here we report a case of acute, severe but substantially reversible, neuromuscular and cardiac toxicity following XELOX chemotherapy. Muscle biopsy findings were consistent with a toxic myopathy with necrotizing features and vacuolar changes; COX-negative fibers were also present. The time course could support a main role for capecitabine, which may have some neurotoxic effects (more frequently central), but a detrimental interaction between the two drugs cannot be ruled out and further studies are needed.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capecitabine
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / pathology
  • Colorectal Neoplasms / drug therapy
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / therapeutic use
  • Humans
  • Middle Aged
  • Neuromuscular Diseases / chemically induced*
  • Neuromuscular Diseases / diagnosis
  • Neuromuscular Diseases / pathology
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil